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Purpose: To evaluate the usefulness of epithelial corneal sheets mounted on platelet poor plasma (PPP) for allograft
transplantation of rabbits with total limbal stem cell deficiency (LSCD) and to prove its efficacy at 1 year after surgery.
Methods: LSCD was induced in 21 female rabbits by mechanical keratectomy. To configure the grafts, limbal biopsies
were taken from male rabbits and cells were cultured on a fibroblast feeder layer grown on clotted autologous PPP. After
keratectomy, grafts were sutured over the stroma. Control groups consisted of no implant or an implant of clotted PPP.
Rabbits were euthanized at 3 and 12 months. Corneas and cultured sheets were processed for histopathology and
immunohistochemistry (K3/12 and K19). Gender analysis was performed at 4 and 7 months.
Results: One rabbit had endophthalmitis, and another died of no apparent cause. The rest of the animals treated had no
inflammation, showed a stratified epithelium, keratin 3/12 expression, and no expression of keratin 19. At 1 year, seven
of  eight  rabbits  showed  no  LSCD  or  corneal  rejection  signs.  Y  chromosomes  were  detected  at  4  and  7  months
postoperatively. All controls showed LSCD signs, erratic epithelium, and minimal cell differentiation; they revealed a
slight expression of K3/12 and an expression of K19 in patchy patterns.
Conclusions: Allografts contributed to restoring a healthy eye surface without signs of graft rejection. This technique
seems to be a promising procedure for bilateral ocular surface diseases and may be useful for new therapeutic strategies.
Limbal stem cell deficiency (LSCD) can be presented as
recurrent  and  persistent  epithelial  defects  with  surface
irregularities  [1].  This  situation  develops  in  secondary
infection  and/or  long-term  inflammation,  leading  to
secondary corneal opacification and neovascularization. The
most severe sequelae to LSCD is corneal conjunctivalization,
which is believed to be the consequence of the inability of
corneal epithelial cells to regenerate properly.
Treatment  of  corneal  LSCD  is  a  trim  challenge  in
ophthalmology  [2-4].  Different  diseases  (such  as  aniridia,
chemical, or thermal injury, ocular cicatricial pemphigoid, or
Stevens  Johnson  syndrome),  contact  lens  wear,
antimetabolites,  massive  keratitis,  as  well  as  multiple
surgeries can cause LSCD.
Patients  with  this  condition  are  poor  candidates  for
conventional corneal transplantation because grafting of the
central  cornea  does  not  restore  limbal  cells  [5].  Limbal
autografts cannot always be performed, and limbal allografts
carry potential graft-rejection disadvantages. In addition, the
long-term outcome of the reconstructed epithelial surface is
plagued with persistent epithelial defects, inflammation, and
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higher risk of secondary infection, which in turn can lead to
revascularization  and  opacity  of  the  corneal  tissue.  This
pathological  process  promotes  corneal  instability,  causing
serious discomfort and morbidity to the patient [6].
Advances in corneal limbal epithelial cell culture have
enabled researchers to develop new treatments [7]. The use of
autologous grafts of functional epithelial corneal cell layers
in humans was first described by Pellegrini et al. [8] in 1997,
and since then several clinical protocols have started to test
this new therapy [9-14]. This technique has some advantages
over  the  classic  limbal  transplant,  such  as  reduced
postoperative  inflammation  [15].  Although  some  patients
have been treated with this innovative therapy and have shown
favorable results, more animal and clinical studies are still
required to establish a treatment of proved efficacy for patients
with LSCD [16-19].
The  situation  is  completely  different  in  patients  with
bilateral corneal stem cell deficiency where there is no healthy
limbus to obtain the cells from. The therapeutic options for
these patients include the use of allogenic limbal epithelial
cells or an alternative source of healthy autologous epithelial
cells that can mimic limbal epithelial cells. For the first option,
living related donors or cadaveric corneas are required [20,
21].
The use of supporting materials for transportation and
transplantation of cultured epithelial cell sheets onto patients
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2771has improved the reproducibility of the technique. Materials
most widely used include amniotic membrane [22-24] and
fibrin glue [25]. The former presents potential benefits for
epithelial  cell  adhesion,  proliferation,  and  differentiation,
while fibrin may be more convenient for interactions between
the epithelium and stromal cells after surgery [26].
Surgical  tissue  adhesives  have  been  developed  to
promote  hemostasis  and  tissue  sealing  during  surgery.
Polymerizing fibrinogen with thrombin and calcium forms
fibrin glue. When mixed together, these agents mimic the last
stages of the clotting cascade to form a fibrin clot. Fibrinogen
can be obtained from pooled, single-donor, or autologous
blood  and  is  usually  isolated  by  the  process  of
cryoprecipitation.  The  tensile  strength  and  adhesive
properties of the glue are proportional to the concentration of
fibrinogen [27]. The thrombin component is generally derived
from commercial bovine sources, which represents a risk for
disease transmission.
It is worth mentioning the recent use of platelet poor
plasma (PPP) as a cell supporter in corneal limbal epithelial
cell transplantation [16]. We have been testing the use of
plasma  components  with  the  aim  of  developing  new
techniques  in  the  setting  of  experimental  corneal  surgery
[28]. PPP can be clotted with the use of CaCl2. Clots can be
easily handled in surgery and can simplify the transport of cell
sheets. Once implanted on the surgical site, absorption of the
PPP  is  rapidly  achieved  during  wound  healing.  Its
biocompatible and biodegradable properties prevent it from
inducing foreign body reactions or extensive fibrosis [29].
PPP has no adhesive properties and, for this reason, the cell
sheet has to be attached to the cornea with the aid of sutures
or tissue glue.
In this study we intend to show the usefulness of epithelial
corneal cell sheets mounted on a PPP support for allograft
transplantation of rabbits with total LSCD. We also aim to
prove its efficacy at 1 year postoperatively.
METHODS
Animals:  Thirty-one  New  Zealand  White  rabbits  (CNEA,
Argentina) weighing approximately 3,000 g each were used.
Ten male rabbits acted as limbal donors. A sample of 13 ml
of blood was drawn under strict aseptic conditions using a 21
G  needle  from  each  of  the  21  female  rabbits.  A  syringe
preloaded  with  1.3  ml  of  Anticoagulant  Citrate  Dextrose
solution  was  used  to  avoid  coagulation.  A  15  min
centrifugation at 72× g at 4 ºC was carried out in order to
separate the plasma from the red and white cells; the plasma
was then centrifuged for another 5 min at 1,000× g to obtain
7 ml of PPP in the upper part of the tube. PPP was stored in a
sterile tube at –20 °C. The rabbits were treated in accordance
with the guidelines of the Association for Research in Vision
and Ophthalmology, Inc.: Statement for the Use of Animals
in Ophthalmic and Vision Research [30].
Biopsy, culture, and expansion of cells: A 2.5-mm2 biopsy of
corneal limbal epithelial cells was obtained from the superior
temporal part of the limbus of 10 male rabbit eyes, using a 1.8-
mm-diameter  trephine  and  a  delicate  forceps.  This  was
preceded by gentle debridement of the conjunctiva and rinsing
of the zone with saline to diminish cell contamination in the
culture. The sample was immediately placed in a tube with
Ham’s  F12  containing  100  U/ml  penicillin,  100  μg/ml
streptomycin (Penicillin-Streptomycin, Gibco, Grand Island,
NY), 2.5 μg/ml amphotericin B (Sigma-Aldrich, St. Louis,
Mo), and 20 μg/ml gentamicin (Gibco) and transported to the
laboratory.
The  sample  was  washed  three  times  in  antibiotic-
antimicotic solutions. A fourth wash removed the undesirable
antimicrobials, and a fifth wash was used to perform sterility
tests. The sample was enzymatically processed with trypsin
(Invitrogen, Carlsbad, Ca) to obtain isolated cells. The rabbit
limbal  epithelial  cells  were  seeded  on  a  feeder  layer  of
irradiated murine 3T3 fibroblasts and cultured in growing
medium composed of a 3:1 mixture of Dulbecco's modified
Eagle's  Medium  and  Ham´s  F12  (Hyclone,  Logan,  UT)
supplemented with 10% fetal bovine serum, (Internegocios,
Argentina), 0.4 μg/ml hydrocortisone (Sigma-Aldrich), 5 μg/
ml transferrin (Gibco, Grand Island, NY), 5 μg/ml insulin
(Sigma-Aldrich, Germany), 10-10 M cholera toxin A (Gibco,
Carlsbad,  CA),  1.8  x10-4  M  adenine  (Sigma-Aldrich),  2
x10-11  M  triiodothyronine  (Sigma-Aldrich),  100  U/ml
penicillin, and 100 μg/ml streptomycin and placed in a 37 °C,
5% CO2 incubator. Once several colonies were grown, the
feeder layer was detached from the culture flask, single cell
suspensions were obtained from each culture, and cells were
counted and seeded again or cryopreserved in the presence of
10%  dimethyl  sulfoxide  (Sigma-Aldrich)  and  20%  fetal
bovine  serum  (Internegocios,  Argentina)  in  a  density  of
approximately 106 cells/ml.
Graft assembling: Autologous PPP (extracted from the blood
from rabbits with LSCD) was activated with CaCl2, which
inhibits  the  blood-thinning  effect  of  acid  citrate  dextrose
solution. PPP was clotted in two circular culture chambers.
Approximately 4×104 male rabbit limbal epithelial cells/cm2
were seeded on a fibroblast feeder layer grown on each PPP
clot,  and  cells  formed  a  monolayer  after  a  few  days.  To
achieve  cell  stratification,  epidermal  growth  factor
(Invitrogen, Carlsbad, CA) was added to the culture medium
to a final concentration of 10 ng/ml 4 days before surgery. In
all  cases,  culture  media  were  supplemented  with  50,000
Kallikrein  inhibitory  units/ml  aprotinin  (Teva-Tuteur,
Argentina) to prevent fibrinolysis. At the time of surgery all
grafts contained a stratified cell sheet and could be easily
detached from the chambers with forceps. Dehydration of the
grafts during surgery was avoided with the application of
hydroxypropyl methylcellulose drops every 5 min. Otherwise,
serious damage to the grafted cells would ensue.
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anesthesia  using  a  combination  of  intramuscular  1  mg/kg
midazolam  (Roche,  Basel,  Switzerland)  and  70  mg/kg
ketamine  (Fada,  Buenos  Aires,  Argentina)  and  topical
anesthesia using sub-Tenon’s capsule injection of 1 ml of 4%
lidocaine and proparacaine drops.
LSCD was induced in 21 female rabbits by mechanical
deep  anterior  keratectomy,  including  the  limbus  (Figure
1A,B). Fifteen female animals received corneal epithelial cell
sheet grafts that covered the entire cornea and were sutured
with  nylon  10.0  to  the  sclera.  These  sheets  replaced  one
anterior third of the removed stroma and fit over the limbal
margins.  Post-surgical  treatment  included  topical  0.3%
ciprofloxacin (Bausch & Lomb, Buenos Aires, Argentina)
given four times daily for 2 weeks and prednisolone 10 mg/
ml (Allergan, Irvine, TX) given four times daily for 30 days.
Clinical follow-up was performed for up to 1 year.
The  control  group  was  divided  into  two  subgroups
according  to  the  post-anterior  keratectomy  treatment
received.  Control  group  1  consisted  of  three  animals  that
received no treatment after keratectomy and were sacrificed
at 3 months. Control group 2 was formed by three animals,
which were sutured with PPP clots lacking stem cell sheets
and were followed for 1 year.
Histopathology  and  immunofluorescence:  Animals  were
sacrificed for corneal ablation. Five treated female rabbits and
control group 1 were sacrificed at 90 days and the rest of the
animals at 1 year. Corneal samples were cut at 10 μm thickness
in a cryostat and processed for histopathological examination
(hematoxilin  and  eosin  staining)  as  well  as  for
immunofluorescence  studies  to  identify  the  expression  of
keratins in the corneal epithelium. Grafts were studied in the
same way. mAb AE5 against keratins 3 and 12 (Chemicon,
Temecula, CA) and mAb E6 against keratin 19 (Chemicon)
were used. Briefly, sections were incubated overnight in a
humid chamber at 4 °C with primary antibody diluted in PBS
containing 0.2% (w/v) bovine serum albumin, 0.03% (v/v)
Triton X-100, and 0.1% (w/v) sodium azide. Dilutions used
were 1:300 for mAb anti K3/12 and 1:600 for mAb anti K19.
After rinsing with PBS, sections were incubated for 60 min at
20  °C  with  biotinylated  goat  antimouse  IgG  (Vector,
Burlingame, CA) followed by fluorescein-labeled antibiotin
(Vector).
Gender analysis: In month 4 of the follow-up period, two
female rabbits were randomly selected to obtain a limbal
biopsy. In month 7, another two rabbits were biopsied as well.
A 2-mm diameter trephine, a blade number 11, and a delicate
forceps were used to perform a 4 mm2 superficial flap of
corneal epithelium in the superior corneal periphery. Each
sample  was  transported  to  the  laboratory,  and  cells  were
expanded by single-cell suspension culture as described above
and cryopreserved at −196 °C. Classic cytogenetic studies
were carried out according to established protocols. Briefly,
cells were thawed, seeded at approximately 3.103 cells/cm2,
and cultured until semiconfluence. To obtain metaphases, the
following steps were followed: 2 h exposure to colchicine,
feeder layer detachment, hypotonic shock in 0.075 M KCl,
and  3:1  methanol–acetic  acid  fixation.  Metaphases  were
karyotyped using G banding. G bands were obtained using
Wright stain as follows: after 2 weeks at room temperature in
dark containers, slides were pretreated for 20 s in 2× standard
saline citrate solution (SSC) at 65 °C, washed with distilled
water,  and  covered  with  a  1:2  Wright  stain–Sorensen
buffer for 2.5 min. Slides were quickly washed with abundant
tap water and left in the dark until microscopic observation.
G-banded  slides  were  photographed  at  1000×  with  an
Olympus  photomicroscope  registering  each  metaphase’s
landmarks. A minimum of 40 metaphase cells was examined
for each individual.
RESULTS
Treated group: A good stratified epithelium of four layers was
achieved in all grafts by the time of surgery (Figure 1C).
Autologous  PPP  clots  showed  good  elasticity  and
transparency, facilitating the follow-up of cultures and the
surgical technique. The grafts as well as the clots perfectly
tolerated eight noncontinuous 10.0 nylon sutures (Figure 1D).
Dehydration of PPP could be prevented during surgery. The
right side up position of epithelial cell sheet grafts was clearly
identified, and no rollover was experienced. There were no
Figure 1. Allograft of corneal epithelial cell sheet on autologous platelet poor plasma clot. A, B, D: Once the lamellar keratectomy is performed,
the rabbit stromal surface is covered with a corneal epithelial cell sheet, which is sutured with eight noncontinuous 10.0 nylon sutures. C: The
corneal epithelial cell sheet presents a stratified epithelium consisting of four layers, inferior cells are polygonal and disclose a prominent
nucleolus while cells of mid epithelium show irregular morphology, and superficial cells are flattened with a compact ovoid nucleus of
homogeneous chromatin.
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2773complications  during  the  surgical  procedure,  with  the
exception of a small corneal perforation in one animal that
evolved satisfactorily, achieving a clear cornea at the end of
the protocol.
As  expected,  minimal  signs  of  postoperative  keratitis
were seen until the second week. Of the 15 treated female
rabbits, five were sacrificed at 90 days and eight at 1 year for
histopathology  and  immunofluorescence  studies.  Of  the
remaining rabbits, one died of no apparent cause at 1 month
and  the  other  had  to  be  sacrificed  at  1  month  because  it
progressed to microbial keratitis in the first weeks, did not
respond to antibiotic therapy, and ended with a severe corneal
infection and endophthalmitis.
At 1 year, only one animal out of eight showed a clinical
sign of LSCD (one clock hour neovessel; Figure 2A), one
presented a mild stromal leucoma in one quadrant (Figure
2D), and one developed neovascularization of one-quarter of
the cornea at 4 months post surgery that began to regress
thereafter without treatment to show no signs of neovessels at
12 months of follow-up (Figure 3). The remaining five rabbits
showed a normal corneal surface, without epithelial defects
(Figure  2B,C,E–G).  Corneal  clarity  evolved  toward
improvement over time. The pupillary margin and the iris
crypts could be identified in all animals. Corneal rejection, as
described by Maumenee [31], was not seen.
At 90 days and at 1 year, histological corneal sections
revealed a multilayered configuration with maturation from
polygonal basal cells to flat superficial cells. Beneath the
epithelium, an acellular colagenous hyaline layer with isolated
keratocytes could be observed. The median and deep stroma
as well as the Descemet membrane and endothelium showed
a normal appearance (Figure 4A). Epithelial-like cells with
clear cytoplasm at the basal layer of the corneal epithelium
were  seen,  and  a  slightly  Periodic  Acid  Schiff-positive
acellular layer compatible with the basement membrane could
be observed (Figure 4B). There were neither signs of vascular
pannus  nor  avascular  intraepithelial  mucin  cells  on  the
implanted corneas. At the central area of the cornea, besides
a  thin  homogenous  layer  beneath  the  epithelium,  the
remaining  corneal  stroma  disclosed  a  normal  lamellar
Figure 2. Clinical results at 1 year after surgery. Five eyes of the treated group displayed avascular and re-epithelialized corneas, with no signs
of limbal stem cell deficiency (B, C, E, F, and G), one animal showed corneal neovascularization (A), one stayed with a stromal leucoma
(D) and the other suffered from neovascularization that regressed thereafter leaving a stromal leucoma (H). Figure I shows one eye of the
control group with no implant, at 3 months. The 3 animals of the control group implanted with PPP showed signs of limbal stem cell deficiency:
one rabbit had to be sacrificed at 120 days because of a severe infection due to a IV grade corneal abscess (J), another spontaneously died at
240 days showing a small inferior leucoma and epithelial defects (K) and the remaining rabbit displayed total irregularity of the corneal surface
at one year after surgery (L).
Molecular Vision 2009; 15:2771-2779 <http://www.molvis.org/molvis/v15/a292> © 2009 Molecular Vision
2774configuration with interspread keratocytes (Figure 4C). In the
peripheral cornea, a thick layer of proliferated myofibroblasts
and  colagenous  disposition  deposits  containing  a  few
inflammatory cells was present between the epithelium and
the remaining corneal stroma (Figure 4D).
Immunofluorescence results showed expression of K3/12
and no expression of K19 (Figure 5C,D), similar to the pattern
found  in  a  normal  corneal  epithelium  (Figure  5A,B).
Expression  of  keratins  on  cultured  epithelial  sheet  grafts
showed  basal  expression  of  K19  and  suprabasal-layer
expression  of  K3/12  (Figure  5G).  Allogenic  donor
chromosomes could be detected in one of the two rabbits
biopsied at each time (4 and 7 months after surgery).
Control group C1 (no sheet, no platelet poor plasma, 90
days): All animals showed limbal ischemia and persistent
epithelial defects (defined as epithelial defects for more than
2 weeks after initial epithelialization). They suffered from
irregular corneal surface with moderate stromal ulcers. Two
rabbits  developed  neovascularization  after  75  days.
Visualization of the pupillary margin was fairly blurry (Figure
Figure 3. Neovascularization regression in one treated animal. One treated animal developed neovascularization of one-quarter of the cornea
at 4 months after surgery (A) that began to regress thereafter without treatment to show no signs of neovessels at 12 months of follow-up
(D). B and C show corneal appearance at 8 and 10 months, respectively.
Figure 4. Histological results at 1 year. Histological corneal sections of treated animals (A–D) show an implanted corneal epithelium of a
multilayer configuration with maturation from polygonal basal cells to flat superficial cells. Beneath the epithelium there is an acellular
colagenous hyaline layer (arrows) with isolated keratocytes. The median and deep stroma as well as the Descemet membrane and endothelium
have a normal appearance (hematoxylin and eosin stain; A). Periodic acid-Schiff  stain shows epithelial-like cells with clear cytoplasm at the
basal layer of the corneal epithelium with a continuous basement membrane. A slightly periodic acid-Schiff positive acellular layer is seen
between the epithelium and the normal corneal stroma (arrows; B). At the central area of the cornea, besides a thin homogenous layer beneath
the epithelium, the remaining corneal stroma disclosed a normal lamellar configuration with interspread keratocytes (Masson stain; C). In the
peripheral cornea, a thick layer of proliferated myofibroblasts and colagenous disposition deposits containing a few inflammatory cells is
present between the implanted epithelium and the remaining corneal stroma (Masson stain; D). In the control group (E–H) an irregular
regenerative epithelium from the limbal conjunctiva can be distinguished over the remaining stroma and a subepithelial scarring with
inflammatory cells and neovascularization is present (Hematoxylin and eosin stain; E). A taller epithelium compared to normal/treated corneas
is evident, with incomplete surface cell differentiation (Hematoxylin and eosin stain; F). Periodic acid-Schiff of the peripheral cornea discloses
the presence of goblet cells within the corneal epithelium and a scarring of the underlying corneal stroma (G). Central cornea of a control eye
shows a multilayered squamous-like corneal epithelium and a thick layer of active scar containing myofibroblasts, colagenous deposits, and
inflammatory cells at the interface within the remaining corneal stroma (Masson stain; H).
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27752I). Histological sections revealed a thin regenerative and
erratic epithelium with minimal surface cell differentiation
and pronounced fibroblastic proliferation (data not shown).
Basement membrane could not be distinguished. An elevated
expression of K19 and weak expression of K3/12 were found
(data not shown).
Control group C2 (no sheet, platelet poor plasma clot, 1 year):
One animal died at 240 days of no apparent cause, and another
had to be sacrificed at 120 days because of a severe infection
due to a IV grade corneal abscess [32].
All rabbits developed limbal ischemia at 90 days and
showed persistent epithelial defects and an irregular corneal
surface with multiple stromal ulcers, which caused a blurry
vision of the pupillary margin, and almost no distinguishable
iris crypts at the same time. These animals showed LSCD
signs  with  corneal  keratitis,  epithelial  irregularities,  and
vascularization of the center and periphery of the cornea. At
1year total irregularity of the corneal surface was seen (Figure
2L).
The rabbit that spontaneously died at 240 days showed a
small inferior leucoma and epithelial defects in two clockwise
hours (Figure 2K). At the time of sacrifice, the rabbit with the
corneal  abscess  presented  permanent  360o  corneal
neovascularization and a large central opacity that hindered
visualization of the pupil (Figure 2J).
Histological sections revealed an irregular regenerative
epithelium from the limbal conjunctiva over the remaining
stroma and a subepithelial scarring with inflammatory cells
and  neovascularization  (Figure  4E).  A  taller  epithelium
compared  to  normal/treated  corneas  was  evident,  with
incomplete  surface  cell  differentiation  (Figure  4F).
Intraepithelial mucin cells could be identified in one animal
Figure 5. Immunofluorescence at 1 year. A normal corneal epithelium presents K3/12 (A) expression but no expression of K19 (B). Corneas
of treated eyes also express K3/12 (C) but not K19 (D). In corneas of control 2 K3 is slightly expressed (E) and K19 is expressed in a patchy
and erratic pattern (F). Table G discloses immunofluorescence results for central and peripheral corneas of normal, treated, and control eyes.
Treated eyes show a similar expression than a normal eye, with strong K3/12 expression along the entire cornea, no expression of K19 in
central cornea and a slight mark for K19 in the periphery. Both control groups express K19 along the central and peripheral cornea. Cultured
epithelial sheet grafts show basal expression of K19 and suprabasal-layer expression of K3/12.
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2776at 120 days (Figure 4G). All animals showed a multilayered
squamous-like corneal epithelium and a thick layer of active
scar  containing  myofibroblasts,  colagenous  deposits,  and
inflammatory  cells  at  the  interface  within  the  remaining
corneal  stroma  (Figure  4H).  indirect  immunofluorescence
revealed  slight  K3/12  expression  (Figure  5E).  K19  was
expressed in a patchy pattern (Figure 5F).
DISCUSSION
Our  results  demonstrate  that  full  thickness  allografts  of
bioengineered limbal epithelium mounted on an autologous
PPP  support  can  be  an  alternative  treatment  for  corneal
allograft transplantation. The implanted cell sheets favored re-
epithelialization and survived for a long period of time without
the  use  of  systemic  chronic  immune  suppression.  The
promising results observed at 90 days post surgery could still
be confirmed at 1 year post surgery.
To our knowledge, this is the first report on the use of
autologous plasma and calcium as support for homologous
epithelial  cell  sheets.  This  method  provides  not  only  an
economic advantage over commercially available fibrin glues
but also a safer matrix with respect to disease transmission
and immunogenicity. In vitro allogenic epithelial cells could
be satisfactorily grown over PPP clots.
Autologous  PPP  clots  are  easily  handled,  which
facilitates the grafting of limbal corneal epithelial cell sheets.
No difficulties were encountered with the suture technique
since the graft was elastic and strong enough to tolerate eight
noncontinuous 10.0 nylon sutures. Autologous PPP is a cost-
effective option and its obtainment and the cell cultures have
been  carried  out  following  standard  procedures.  The
transparency of the PPP clots simplified follow-up of cell
sheet cultures.
Disease or destruction of the corneoscleral limbus leads
to ingress of conjunctiva-derived cells, including goblet cells,
and blood vessels onto the normally avascular corneal surface,
affecting  its  optical  properties  and  leading  to  visual
impairment or blindness [33]. Immune privilege of the eye has
long been known as the mechanism by which the majority of
orthotropic corneal allografts are permanently accepted [34].
It is believed that this immune privilege is actively acquired
and maintained by immune regulatory forces in the eye. These
forces include the avascular nature of the cornea and the
presence of local inhibitory factors in corneal epithelial and
endothelial cells [35]. Since we grafted male allograft cells
over  a  denudated  female  corneal  and  limbal  stroma,  we
expected to observe minimal signs of graft rejection, but none
of the treated animals showed this complication. The corneal
epithelium  was  found  to  be  clinically  and
immunohistologically  normal,  evidencing  nonpathological
re-epithelialization. No signs of immunological reaction were
seen  during  follow-up  after  allogenic  transplantation,
including  epithelial  rejection.  This  unwanted  condition,
defined  as  an  epithelial  line  (Khodadoust  line)  or  diffuse
punctate  corneal  epitheliopathy  plus  diffuse  conjunctival
inflammation is fairly frequent in lamellar keratoplasty [36].
A possible explanation for this desirable outcome is that graft
rejection occurs in a chronic way, allowing the graft to work
as a support for the regeneration of part of the host stem cell
population. This estimation is in line with the observations of
Daya et al. [37] who investigated the outcome of an ex vivo
expanded stem cell allograft as a treatment for LSCD in 10
patients. They analyzed donor cell survival in seven patients,
using PCR, and could prove it only in two patients but not
beyond 9 months postoperatively. The methodology used by
us  to  detect  the  presence  of  donor  DNA  has  inherent
limitations in sensitivity but not in accuracy; this means that
the presence of the Y chromosome undoubtedly indicates that
there  are  donor  cells  still  present  in  the  cornea,  but  no
conclusion  can  be  made  based  on  the  absence  of  the  Y
chromosome.  Indeed,  the  percentage  of  XY  metaphases
determined  in  each  sample  depends  on  the  proliferative
capacity of the cultured cells and the isolation procedure and
has no relation to the percentage of XY cells present in the
epithelium. At the same time, a negative result does not prove
the absence of donor cells in the biopsy. We consider very
interesting  the  fact  that  donor  cells  forming  part  of  the
epithelium  of  treated  eyes  could  be  found  at  7  months
postoperatively,  especially  when  the  biopsy  was  obtained
from  the  corneal  periphery  where  the  probability  to  take
autologous cells is augmented, because those donor cells that
we  could  expand  in  vitro  must  have  maintained  an
undifferentiated state to stay at the corneal periphery for such
a long time. Demonstrating the persistence and acceptance of
an XY genotype graft over an XX receptor is of paramount
importance in the pursuit of a successful therapeutic strategy.
Furthermore, these allogenic grafts might be useful for corneal
gene delivery to treat some corneal epithelial dystrophies of
genetic origin, such as Meesmann dystrophy [38].
Corneal neovascularization can lead to vision loss and it
is often difficult to manage. Newly or already formed corneal
neovessels elevate the risk of subsequent graft rejection after
corneal transplantation [39]. Medical and surgical therapies
used  to  reduce  corneal  neovessels  include  corticosteroids,
nonsteroidal  anti-inflammatory  agents,  laser
photocoagulation, needle diathermy [40], and recently, the use
of bevacizumab [41]. Many of these therapies have not only
demonstrated  limited  success  but  also  demonstrated
associated adverse effects. As is seen in patients, once graft
rejection  occurs,  graft  failure  ensues,  and  a  second
keratoplasty and limbal graft is required to restore the ocular
surface.  In  our  study,  corneal  neovascularization  with
spontaneous resolution only occurred in the treated group.
With this favorable result, we remark on the usefulness of the
implanted grafts to maintain the integrity and healthiness of
the cornea.
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2777In general, a favorable outcome—defined as clear cornea
—could be detected at 30 days post surgery. In the treated
group, corneal transparency remained unchanged up to 1 year
of follow-up. Clear nonmucin-secreting cells were seen on the
implanted  animals  as  seen  on  lamellar  corneal  implanted
humans, probably as a result of constant re-epithelization,
which  may represent transient amplifying cells. In contrast,
in  the  control  groups,  corneal  neovascularization,  surface
irregularities, and opacity started to be visible from week 3
until the end of the protocol. Based on these findings, we
conclude that the persistence of the implanted tissue and the
healing of the receptor limbus jointly avoid, in turn, corneal
invasion of the conjunctiva and corneal neovascularization.
Keratins  19  and  3/12  have  been  chosen  merely  to
compare the expression of normal treated and control corneal
epithelium. At present, there are no consistent data that can
relate clinical success to a determined expression pattern. To
characterize the putative corneal stem cells, the presence of
morphologic  features  and  several  markers  are  used  in
combination  with  the  absence  of  cornea-specific
differentiation markers, but the identification of limbal stem
cells is still under debate [42].
The above results and the keratin immunofluorescence
outcomes  suggest  that  cultivated  limbal  epithelial
transplantation is a useful approach to the treatment of LSCD,
restoring a feasible microenvironment in the ocular surface
and securing a corneal epithelial phenotype.
In conclusion, the allograft corneal epithelium was able
to  restore  and  maintain  a  healthy  eye  surface  appearance
without signs of graft rejection. The reported technique seems
to be a promising procedure for the treatment of bilateral
ocular  surface  diseases  and  constitutes  an  important  step
toward  the  development  of  a  new  therapeutic  strategy  in
patients. The access to corneas from eye banks is a difficult
and expensive option, and people with bilateral LSCD would
benefit from allografts of epithelial corneal sheets cultured on
PPP clots as support.
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